
IFLScience
shared a link post in group #IFLScience

www.iflscience.com
New Alzheimer’s Drug Halts Disease Progression In 47 Percent Of Trial Patients After 1 Year
The drug could soon be licensed for use, but some have called for caution until the full dataset is available.
